SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-13-026408
Filing Date
2013-01-28
Accepted
2013-01-28 17:30:00
Documents
2
Group Members
DAVID SCHNELLPROSPECT MANAGEMENT CO. II, L.L.C.PROSPECT MANAGEMENT CO., L.L.C.PROSPECT VENTURE PARTNERS, L.P.RUSSELL C. HIRSCH

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d475423dsc13ga.htm SC 13G/A 128090
2 EX-A d475423dex991.htm EX-99.1 7807
  Complete submission text file 0001193125-13-026408.txt   137793
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 6174531000
INFINITY PHARMACEUTICALS, INC. (Subject) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-60943 | Film No.: 13552821
SIC: 2834 Pharmaceutical Preparations

Mailing Address 435 TASSO STREET SUITE 200 PALO ALTO CA 94301
Business Address 435 TASSO ST STE 200 PALO ALTO CA 94301 6503278800
PROSPECT VENTURE PARTNERS II LP (Filed by) CIK: 0001135669 (see all company filings)

IRS No.: 770565416 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A